Scinai Immunotherapeutics (SCNI) Free Cash Flow (QoQ) (2019 - 2025)
Scinai Immunotherapeutics (SCNI) Free Cash Flow (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.62 Bn | 466.83 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Scinai Immunotherapeutics | 3.74 Bn | 627.11 Mn | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -48.35% |
| Mar 31, 2025 | 6.18% |
| Dec 31, 2024 | 45.92% |
| Sep 30, 2024 | -16.10% |
| Jun 30, 2024 | -19.92% |
| Mar 31, 2024 | 35.50% |
| Dec 31, 2023 | -2.86% |
| Sep 30, 2023 | 11.88% |
| Jun 30, 2023 | 18.15% |
| Mar 31, 2023 | -53.03% |
| Dec 31, 2022 | -9.50% |
| Sep 30, 2022 | 49.68% |
| Jun 30, 2022 | -122.69% |
| Mar 31, 2022 | 20.41% |
| Dec 31, 2021 | 66.96% |
| Sep 30, 2021 | 20.77% |
| Jun 30, 2021 | -576.84% |
| Mar 31, 2021 | 92.71% |
| Dec 31, 2020 | -127.02% |
| Sep 30, 2020 | 33.83% |